REFERENCES

Adebola T Olayink, Akin Oyemakinde, Muhammad S Balogun, Anthonia Ajudua, Patrick Nguku,
et al. (2016) Seroprevalence of Hepatitis B infection in Nigeria: A national survey. Am J
Trop Med Hyg 95: 902-907.
Adegbesan-Omilabu M, Okunade KS, Gbadegesin A, Olowoselu OF, Oluwole AA,. (2015)
Seroprevalence of Hepatitis B virus infection among pregnant women at the antenatal
booking clinic of a Tertiary Hospital in Lagos Nigeria. Niger I Clin Pract 18: 819-823.
Adeniyi, N.A., Zakariyahu, T.O., Shittu, M.O., Akinfenwa, J. and Atiba, A. (2015). Sero-
Epidemiology of Hepatitis B Surface Antigen among Intending Blood Donors in Ogbomoso,
South West Nigeria. Journal of Pharmacy and Biological Sciences, 10:89-91.
Adewole, O. O., Anteyi, E. A., Ajuwon, Z. O., Wada, I., Elegba, F.,more, & Ojuawo, A. (2015).
Hepatitis B virus infection in Nigeria —A review. Nigerian Medical Journal, 56(4), 161.
Adeyemi AB, Enabor 00, Ugwu IA, Abraham OA, Bello FA, et al. (2014) Prevalence of antenatal
Hepatitis B infection in tertiary and non tertiary health facilities in Ibadan, Nigeria. Niger J
Med 23: 248 253.
Aernan, P.T., Sar, T.T. and Torkula, S.H. (2011). Prevalence of Plasmodia and hepatitis B virus co-
infection in blood donors at Bishop Murray Medical Centre, Makurdi, Benue State Nigeria.
Asian Pacific Journal Tropical Medicine, 4:224-226.
Agbede UU, Isenyi JU, Kolewale MU, Ujuwa A (2007) Risk factors and seroprevalence of
Hepatitis B antigenemia in mothers and their preschool children in Ilorin, Nigeria. Therapy
4: 67 72.
Ahizechukwu, C.N., Uzoamaka, A.E., Charles, I.O. and Ifeanyichukwu, U.E. (2011). Prevalence,
Correlates and Pattern of Hepatitis B Surface Antigen in Low Resource Setting. Virology
Journal, 8:12.
Ajuwon Busayo. I, Isabelle Yujuico, Katrina Roper, Alice Richardson, Meru Sheell and Brett A.
Lidbury , Hepatitis B virus infection in Nigeria: a systematic review and meta-analysis of
data published between 2010 and 2019 (2021) 21:1120https://doi.org/10.1186/s12879-021-
06800-6
Akani CI, Ojule AC, Opurum HC, Ejilemele AA. Sero-prevalence of hepatitis B surface antigen
(HBsAg) in pregnant women in Port Harcourt, Nigeria. Niger Postgrad Med J
2005;12:266-70.
Alter MJ (2003) Epidemiology of Hepatitis B in Europe and Worldwide. J Hepatol 39: S64-S69.
Altiparmak, E., Koklu, S., Yalinkilic, M., Yuksel, O. and Cicek, B. (2005). Viral and host causes of
Any do, Li. vini, Ma, DeBaul, S, De aside, old as a 30 2300). Detection of
hepatitis A, B, and C virus-specific antibodies using oral fluid for epidemiological studies.
Memorias do Instituto Oswaldo Cruz, 101:149-155.
Aminu, M., Okachi, E., Bello, M., & Oyim, E. (2015). Prevalence and risk factors for hepatitis B
and C among pregnant women in a tertiary hospital in Nigeria. The Pan African Medical
Journal, 20(1).
Ansari, A.S., Khanani, M.R., Abidi, S.H., Shah, F., Shahid, A. and Ali, S.H. (2011). Patterns of
HIV
infection among native and refugee Afghans. AIDS, 25:1427-1430.
Antai, D., Arikpo, D., Osim, E., & Bami-Ipodun, Y. (2018). Regional inequalities in hepatitis B
infection among Nigerians born before and after the introduction of hepatitis B vaccine.
PLoS One, 13(9), e0202962.
Apurva AM, Jordan JF (2007) Viral Hepatitis and HIV in Africa. AIDS Rev 9: 25-39.
Awoleke JO (2012) Hepatitis B surface antigenaemia among pregnant women in a tertiary health
institution in Ekiti State, Nigeria. Trop I Obstet Gynaccol 29: 34 39.
batholomew, C. (2U1 1). Knowledge, Attitude and Practices (KAP) concerning Hepatitis B among
Adolescents in the Upper West Region of Ghana. The Rural Urban Gradient. Thesis
Department of Public Health and Clinical Medicine Umed University Sweden, 6:12-18.
Belo AC (2000) Prevalence of Hepatitis B virus markers in surgeons in Lagos, Nigeria. East Aft
Med J 77: 283-285.
Berinyuy, B.E, Alawode, R.A, Mohammed, A.B., Babalola, B.S., Mustapha, A., Oshevire, R.M.,
Okunlola, M.B. and Lawal, A. (2019). Prevalence of Hepatitis B Virus in Nigeria: Review
Update Annals of Public Health and Epidemiology, 19:1-9.
Bertoletti, A., & Ferrari, C. (2012). Adaptive immunity in HBV infection. Journal of Hepatology,
57(4), 874-876.
Bhattarai S, KC S, Pradhan PM, Lama S, Rijal S (2014) Hepatitis B vaccination status and needle-
stick and sharps-related injuries among medical school students in Nepal: A cross-sectional
study.
Blumberg, B.S. (1977). Australia antigen and the biology of hepatitis B. Science, 197(4298): 17-25.
Brooks, G.F., Caroll, K.C., Butel, J.S. and Morse, S.A. (2007). Medical Microbiology. (24th edn),
International edition. McGraw Hill Publishers, New York, USA, 425-443.
Centre for disease control and prevention perinatal transmission of HBV 2022
Chang MH (2000) Natural history of Hepatitis B virus infection in children. J Gastroenterol
Hepatol 15: E16-E19.
Chinenye Gloria Anaedobe, Adeola Fowotade, Chukwuma Ewean Omoruyi, Rasheed Ajani
Bakare (2015) Prevalence, socio-demographic features and risk factors of Hepatitis B virus
infection among pregnant women in Southwestern Nigeria. Pan Afr Med J 20: 406.
Culley, S., Towers, G.J., Selwood, D.L., Henriques, R. and Grove, J. (2016). Infection counter:
automated quantification of in vitro virus replication by fluorescence microscopy. Viruses,
8(7):201.
Dane, D.S., Cameron, C.G. and Briggs, M. (1970). Virus-like particles in serum of patients with
Australia antigen- associated hepatitis. Lancet, 1: 696-698.
Egbe, O. B., Eze, J. C., Oguanobi, N. I., Onwe, B. C., Iyare, F. E., & Nwatu, C. B. (2017).
Prevalence of hepatitis B virus surface antigen among pregnant women attending antenatal
chinic in Federal Medical Centre, Umuahia, Nigeria. World Journal of Pharmacy and
Pharmaceutical Sciences, 6(12), 1636-1648.
Ganem, D., & Prince, A. M. (2004). Hepatitis B virus infection natural history and clinical
consequences. New England Journal of Medicine, 350(11), 1118-1129.
GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality
for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease
Study 2016. Lancet 2017; 390: 1151-210.
Gray Davis L, Weber DJ, Lemon SM (1989) Horizontal transmission of Hepatitis B virus. Lancet
1: 889-893.
Hamisu, A. W., Nggada, H. A., & Mava, Y. (2018). Seroprevalence of hepatitis B surface
antigenemia and its effects on hematological parameters in pregnant women attending the
state specialist hospital, Maiduguri, Borno State, Nigeria. International Journal of Medical
and Health Development, 23(1), 31-37.
Harry TO, Bajani MD, Moses AE (1994) Hepatitis B virus infection among blood donors and
pregnant women in Maiduguri, Nigeria. East African Medical Journal 71: 596-597.
Henrietta, O.A. and Maryam, A. (2016). Seroprevalence of hepatitis B virus serological markers
among pregnant Nigerian women. Annals of African Medicine, 15:20-27.
Hou J, Liu Z, Gu F (2005) Epidemiology and prevention of Hepatitis B virus infection. Int I Med
Sci 2: 50-57.
Inan, N. and Tabak, F. (2015). Hepatitis B virus: Biology and life cycle. Viral Hepatitis Journal,
21:1-7.
Janahi, E.M. (2014). Prevalence and Risk Factors of Hepatitis B Virus Infection in Bahrain, 2000
through 2010. PLoS ONE, 9(2):87599.
Joyce, M.T. and Chima, K.E. (2015). Prevalence of hepatitis B surface antigen among residents of
julius berger staff quarters, Kubwa. International Journal of Prevention and Treatment, P
4:29-33.
Kann, M., Schmitz, A. and Rabe, B. (2007), Intracellular transport of hepatitis B virus. World
Journal of Gastroenterology, 13(1):39-47.
Keasler, V.V., Hodgson, A.J,, Madden, C.K. and Slagle, B.L. (2007). Enhancement of hepatitis 13
virus replication by the regulatory X protein in vitro and in vivo, Journal of Virology,
81:2656-2662.
Kehinde, M. O., Lawal, A. O., Aderemi, T. J., Famurewa, O. C., & Alebiosu, C. O. (2017),
Seroprevalence and risk factors of hepatitis B virus infection among pregnant women in
Osogbo, Nigeria. South African Journal of Infectious Diseases, 32(4), 123-127.
Krajden, M., McNabb, G. and Petrie, M. (2005). The laboratory diagnosis of hepatitis B virus. The
Canadian Journal of Infectious Diseases and Medical Microbiology, 16:65-72.
Kramvis A, Kew MC. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical
associations of genotypes. Hepatol Res.2007;37(sl):S9-19
Labpedia. Net, Dr Riaz Hepatitis B structure 2020.
Lee C, Gong Y, Brok I, Boxall EH, Gluud C. Effect of hepatitis B immunisation in newborn infants
of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis.
BMJ 2006; 332: 328-
Levrero, M., Pollicino, T., Petersen, J., Belloni, L., Raimondo, G. and Dandri, M. (2009). Control of
cccDNA function in hepatitis B virus infection. Journal of Hepatology, 51:581-592.
Li X, Zheng Y, Liau A, Cai B, Ye D, Huang F, et al. Hepatitis B virus infections and risk factors
among the general population in Anhui Province, China: an epidemiological study. BMC
Public Health. 2012;12:272.
Liang, T. J. (2009), Hepatitis B: the virus and disease. Hepatology, 49(5), S13-$21.
Lin HH, Kao JH, Chang TC, Hsu HY, Chen DS (2003) Secular trend of age specific prevalence of
Hepatitis B surface and e antigenemia in pregnant women in Taiwan. J Med Virol 69: 466
470.
Liu, B., Wen, X., Zhuan, C. and Wei, Y. (2013). Unraveling the complexity of hepatitis B virus:
From molecular understanding to therapeutic strategy in 50 years. The International Journal
of Blochemistry & Cell Biology, 45: 1987- 1996.
Locarnini, S., & Mason, W. S. (2006), Cellular and virological mechanisms of HBV drug
resistance.
Journal of Hepatology, 44(2), 422-431.
Lok, A.S. (2000). Hepatitis B infection: Pathogenesis and management. Journal of Hepatology,
32:89-97.
Lozano K, Naghavi M, Foreman K, Lim S, Shibuya K, AboyansV, Global and regional mortality
from 235 causes of death
Luka SA, Ibrahim MB, Iliya SN (2008) Seroprevalence of Hepatitis B surface antigen among
pregnant women attending Ahmadu Bello University Teaching Hospital Zaria, Nigeria.
Niger J Parasitol 29: 38 41.
Maléki, A., Abdoul, K.O., Birama, D., Albert, T.Y., Tegwindé, R.C., Dorcas, O., Florencia, W.D.,
Simplice, K. and Jacques, S. (2018). Genetic diversity of hepatitis viruses in West-African
countries from 1996 to 2018 World Journal Hepatology, 10(11): 807-821
Monjezi, R., Tan, S.W., Tey, B.T., Sico, C.C. and Tan, W.S. (2013). Detection of hepatitis B virus
core antigen by phage display mediated TaqMan real-time immuno-PCR. Journal of
Virological Methods, 187(1): 121-126.
Musa, B.M., Bussell, S., Borodo, M.M., Samaila, A.A. and Femi, O.L. (2015). Prevalence of
hepatitis B virus infection in Nigeria, 2000-2013: A systematic review and meta-analysis.
Nigerian Journal of Clinical Practice, 18:163-172.
Ndams IS, Joshua IA, Luka SA, Sadiq HO. Epidemiology of Hepatitis B infection among pregnant
women in Minna, Nigeria. Sci World J. 2008;3(3):5-8. PubMed | Google Scholar
Nelson 2017 Estimating the burden of hepatitis. Lancet, 388: 27382739.
Nwokediuko, S. C., Adeleye, O., Fadeyi, A., Ijoma, U., & Obienu, O. (2014). Seroprevalence of
hepatitis B surface antigen among pregnant women attending antenatal clinic in a tertiary
hospital in Nigeria. Nigerian Journal of Clinical Practice, 17(3), 306-311.
Obi RK, Umch SC, Okurede OH, Iroagba II (2006) Prevalence of Hepatitis B virus infection
among pregnant women in an antenatal clinic in port Harcourt, Nigeria. Afr J Clin Exper
Microbiol 7: 78 82.
Ogunlaja, O.A., Bojuwoye, M.O., Fawole, A.A., Adesina, A.K., Olawumi, H.O. and Ogunlaja, I.P.
(2015). Prevalence of hepatitis B virus infection amongst parturients in the University of
Horin Teaching Hospital Nigeria. Journal of Gastroenterology and Hepatology, 7(1):7-12.
Oguntibeju, O. O., Fasola, F. A., Olubuyide, 1. O., & Olajuyin, A. O. (2017). Sero-prevalence of
hepatitis B surface antigen (HBsAg) among pregnant women attending antenatal clinic in
Osogbo, Nigeria. African Health Sciences, 17(1), 160-165.
Ulaleye, D. U., Ulaosebikan, K., Balogun, M. S., Ulateye, U. A., & Ulaolu, D. 1: (2020).
Seroprevalence of hepatitis B surface antigen among pregnant women attending antenatal
clinic in Lagos University Teaching Hospital, Nigeria. African Health Sciences, 20(2), 980-
988.
Olokoba AB, Salawu FK, Danburam A, Olokoba LB, Midala JK, et al. (2011) Hepatitis B virus
infection amongst pregnant women in North castern Nigeria- a call for action. Niger I Clin
Pract 14: 10 13.
Olokoba, A. B., Salawu, F. K., Danburam, A., & Olokoba, L. B. (2012), Single center study of
prevalence of hepatitis B infection in pregnant women in Nigeria. The World Journal of
Hepatology, 4(8), 244.
Onoh, R. C., Umeora, O. U. J., & Igberase, G. (2015). Hepatitis B virus seroprevalence among
pregnant women attending antenatal clinic at the Federal Teaching Hospital, Abakaliki,
Nigeria. International Journal of Medicine and Medical Sciences, 7(4), 90-94.
Opaleye Oluyinka Oladele, Salami Saheed, Funmilayo Familua, Olowe Olugbenga Adekunle,
Ojurongbe Olusola, Bolaji Oloyede Samuel, Odewale Gbolabo, Ojo Johnson Adeyemi,
Seroprevalence of Hepatitis B Surface Antigen and Antibody among Pregnant Women
Attending a Tertiary Health Institution in Southwestern Nigeria 2014
Pan, C. Q., Duan, Z., Dai, E., Zhang, S., Han, G., & Wang, Y. (2019). Tenofovir to prevent
hepatitis B transmission in mothers with high viral load. New England Journal of Medicine,
374(24), 2324-2334.
Perz, J.F., Armstrong, G. L., Farrington, L.A., Hutin, Y.J. and Bell, B.P. (2006). The contributions of
hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer
worldwide. Journal of Hepatology, 45(4):529-538.
Peter Asaga Mac, Adamu Chipago Suleiman and Philomena Ehi Airiohuodion;Journal of
Infectious
Diseases and Epidemiology; 2019, [PubMed] [CrossRef] [Google Scholar]
Ranger-Rogez S, Denis F. Hepatitis B Mother to Child Transmission. Expert ReAnti-infect Ther.
2004;2(1):133-145. PubMed | Google Scholar
Ryder ST, Beckingham IN (2001) Clinical review: Acute Hepatitis. BMI 322: 151 153.
schweitzer, A., Horn, J. and Mikolajezyk, K.I. (2015). Estimations of worldwide prevalence ot
chronic hepatitis B virus infection: a systematic review of data published between 1965 and
2013. Lancet, 386(10003):1546-1555.
Seeger, C. and Mason, W.S. (2015). Molecular biology of hepatitis B virus infection. Virology, 672-
686.
Sofola 00, Folayan MO, Denloye 00, Okeigbemen SA (2007) Occupational exposure to
bloodborne pathogens and management of exposure incidents in Nigerian dental schools. J
Dent Educ 71: 832-837.
Tong, S., Kim, K.H., Chante, C., Wands, J. and Li, J. (2005). Hepatitis B virus e antigen variants.
International Journal of Medical Science, 2(1): 2-7.
Torbenson, M. and Thomas, D.L. (2002), Occult hepatitis B. Lancet Infectious Diseases, 2:479 486.
Trevor, G.B. and Anna, K. (2016). The Study of hepatitis B virus using bioinformatics.
Available:https://www.intechopen.com/books/bioinformaticsupdated featuresandapplications/
the-study-of-hepatitis-b-virususing-bioinformatics. Accessed April, 28th 2021.
Ugwuja N, Ugwu IC "Hepatitis B virus infection among pregnant women in Nigeria: A
North-South
divide." Nigerian Medical Journal, 2013.)
Ugwuja, E. I., Ogbonnaya, U. O., & Ugwu, N. C. (2017). Seroprevalence of hepatitis B surface
antigen among pregnant women attending antenatal clinic in Federal Medical Centre,
Umuahia, Nigeria. Virology Journal, 14(1), 226.
Umego, C.F., Mboto, C.I., Mbim, E.N., Edet, U.O., George, U.E. and Tarh, J.E. (2018).
Epidemiology of Hepatitis B Virus Infection in South-South, Nigeria: A Review.
International STD Research and Reviews, 7(1): 1-17.
Uneke, C. J., Ogbu, O., & Inyama, P. U. (2007). Prevalence of hepatitis-B surface antigen among
blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria. Memórias
do Instituto Oswaldo Cruz, 102(6), 725-727.
Wai, C.T., Chu, C.J., Hussain, M. and Lok, A.S. (2002). HBV genotype B is associated with better
response to interferon therapy in HBe Ag(+) chronic hepatitis than genotype C. Hepatology,
36(6):1425-1430.
WHO factsheet no. 204. http://www.who.int/mediacentre/fact sheets/fs204/en/. Accessed 14 June
2017
Wiley online Library, Hepatitis B intection and risk factors among pregnant women and their male
partner in baby shower programme in Nigeria 2020
World Health Organization (2009) Hepatitis B vaccines. Weekly epidemiological record. 40: 405-
420.
World health
Organization
(2017). Global hepatitis report. https
://www.who.int/hepatitis/publications/global-hepatitis-report2017-executive-summary/en/.
Accessed April, 2021.
World Health Organization. (2020). Hepatitis B. Retrieved from https://www.who.int/news-
room/fact-sheets/detail/hepatitis-b for 20 age groups in 1990 and 2010: a systematic analysis
for the Global Burden of Disease Study 2010. Lancet
Yakasai IA, Ayyuba R, Abubakar IS, Ibrahim SA (2012) Sero prevalence of Hepatitis B virus
infection and its risk factors among pregnant women attending antenatal clinic at Aminu
Kano Teaching Hospital, Kano, Nigeria. J Basic Clin Reprod Sci 1: 49 55.
Zenebe, Y., Mulu, W., Yimer, M. and Abera, B. (2014). Seroprevalence and risk factors of hepatitis
B virus and human immunodeficiency virus infection among pregnant women in Bahir Dar
city, Northwest Ethiopia: A cross sectional study. BioMed Central- Infectious Diseases,
14:118.
Zhang, H.W., Yin, J.H., Li, Y.T., Li, C.Z., Ren, H., Gu, C.Y. and Cao, G.W. (2008). Risk factors for
acute hepatitis B and its progression to chronic hepatitis in Shanghai, China. Gut,
57(12):1713-1720.